NGS MRD-Guided Blinatumomab Treatment for Pediatric B-ALL
Latest Information Update: 13 Jan 2025
Price :
$35 *
At a glance
- Drugs Blinatumomab (Primary)
- Indications Precursor B-cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 13 Jan 2025 New trial record